Mark Minden

39PUBLICATIONS
296CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 20, 2026
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.

|May 05, 2026
ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

|Apr 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

|Feb 26, 2026
Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells.

Ekaterina N Parfenova, Nikolina Vrdoljak, Drake Mosca

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Jan 02, 2026
A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

Jessie J F Medeiros, Andy G X Zeng, Suraj Bansal

Pageof 7

Frequent Collaborators

9 joint publications

John E Dick

4 joint publications

Sagi Abelson

4 joint publications

Julie A Reisz

4 joint publications

Angelo D'Alessandro